Lazertinib: a novel EGFR-TKI therapy for non-small cell lung cancer

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Lazertinib: a novel EGFR-TKI therapy for non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science